Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Seena Aisner

Concepts (269)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Lobular
1
2022
59
0.670
Why?
Soft Tissue Neoplasms
5
2009
133
0.560
Why?
Bone Neoplasms
4
2008
272
0.450
Why?
Thymus Neoplasms
3
2011
30
0.440
Why?
Diagnosis, Differential
10
2022
1503
0.430
Why?
Carcinoma, Non-Small-Cell Lung
7
2017
1195
0.420
Why?
Lung Neoplasms
10
2017
2675
0.380
Why?
Octreotide
2
2010
23
0.360
Why?
Sarcoma, Alveolar Soft Part
2
2010
6
0.360
Why?
Liposarcoma
3
2009
31
0.350
Why?
Prednisone
2
2010
229
0.340
Why?
Lipoma
2
2009
17
0.330
Why?
Breast Neoplasms
3
2022
2418
0.330
Why?
Antineoplastic Agents, Hormonal
2
2010
196
0.330
Why?
Translocation, Genetic
3
2010
127
0.320
Why?
Neoplasms, Glandular and Epithelial
1
2010
52
0.310
Why?
Proto-Oncogene Proteins c-kit
1
2010
73
0.300
Why?
Chondroblastoma
2
2006
3
0.290
Why?
Biopsy, Fine-Needle
4
2014
79
0.280
Why?
ErbB Receptors
3
2016
636
0.280
Why?
Fibula
1
2008
37
0.270
Why?
Nevus, Spindle Cell
1
2007
1
0.260
Why?
Angiofibroma
1
2007
6
0.260
Why?
Leiomyoma
1
2008
62
0.260
Why?
Biomarkers, Tumor
5
2017
1339
0.250
Why?
Rhabdomyosarcoma, Alveolar
1
2006
7
0.250
Why?
Tibia
1
2008
177
0.240
Why?
Femoral Neoplasms
1
2006
10
0.240
Why?
Head and Neck Neoplasms
2
2012
563
0.230
Why?
Forkhead Transcription Factors
1
2006
209
0.220
Why?
Image Enhancement
1
2006
198
0.220
Why?
Cheek
1
2004
14
0.220
Why?
Facial Neoplasms
1
2004
19
0.210
Why?
Neoplasm Recurrence, Local
6
2017
1160
0.210
Why?
Immunohistochemistry
10
2014
1712
0.210
Why?
Small Cell Lung Carcinoma
2
2016
125
0.200
Why?
Microtomy
1
2003
4
0.190
Why?
Cytological Techniques
1
2003
25
0.190
Why?
Pain
2
2008
790
0.190
Why?
Biopsy, Needle
1
2003
183
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2017
1998
0.180
Why?
Vulvar Neoplasms
1
2022
13
0.180
Why?
Subcutaneous Tissue
1
2022
26
0.180
Why?
Paclitaxel
2
2014
260
0.170
Why?
Breast
1
2022
155
0.170
Why?
Hypothalamus
1
2022
161
0.160
Why?
Middle Aged
25
2019
36619
0.160
Why?
Magnetic Resonance Imaging
3
2008
3926
0.150
Why?
Chromosomes, Human, Pair 11
2
2010
61
0.150
Why?
In Situ Hybridization, Fluorescence
4
2010
334
0.150
Why?
Skin Neoplasms
1
2006
806
0.140
Why?
Vulva
2
2022
24
0.140
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2019
158
0.140
Why?
Humans
38
2022
146342
0.130
Why?
Thymoma
2
2011
38
0.130
Why?
Selenium
2
2017
48
0.130
Why?
Aged
19
2019
26432
0.120
Why?
Bevacizumab
1
2017
169
0.120
Why?
Urinary Bladder
1
2019
194
0.120
Why?
Female
27
2022
79499
0.120
Why?
Erlotinib Hydrochloride
1
2016
71
0.120
Why?
Male
26
2017
73396
0.120
Why?
Carcinoma, Neuroendocrine
1
2016
38
0.120
Why?
Anilides
1
2016
83
0.120
Why?
Disease-Free Survival
4
2013
778
0.120
Why?
Urinary Bladder Neoplasms
1
2019
259
0.120
Why?
Carcinoma
2
2011
225
0.120
Why?
Neoplasm Staging
4
2017
1488
0.110
Why?
Sputum
1
2017
302
0.110
Why?
Adult
18
2017
41087
0.110
Why?
Gene Expression Regulation, Neoplastic
5
2013
1432
0.110
Why?
Antineoplastic Agents, Immunological
1
2017
200
0.110
Why?
Isotretinoin
1
2014
27
0.100
Why?
Proto-Oncogene Proteins c-bcl-2
2
2014
237
0.100
Why?
DNA Methylation
2
2017
725
0.100
Why?
Angiomatosis
1
2013
5
0.100
Why?
Breast Diseases
1
2013
22
0.100
Why?
Vulvar Diseases
1
2013
9
0.100
Why?
Polyps
1
2013
13
0.100
Why?
Adenoma, Oxyphilic
1
2013
7
0.100
Why?
Genes, ras
1
2013
70
0.100
Why?
Receptors, Prostaglandin E, EP3 Subtype
1
2013
3
0.100
Why?
Receptors, Prostaglandin E, EP4 Subtype
1
2013
8
0.100
Why?
Receptors, Metabotropic Glutamate
1
2013
37
0.100
Why?
Hyperplasia
1
2013
164
0.090
Why?
Immunoenzyme Techniques
3
2016
197
0.090
Why?
Interferon-alpha
1
2014
201
0.090
Why?
Pyridines
1
2016
610
0.090
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
2
2010
28
0.090
Why?
Smad Proteins
1
2012
42
0.090
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2009
74
0.090
Why?
Proto-Oncogene Proteins c-mdm2
2
2009
66
0.090
Why?
Genetic Association Studies
1
2013
379
0.080
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2011
20
0.080
Why?
Carcinoma, Squamous Cell
2
2016
628
0.080
Why?
Autophagy
1
2013
290
0.080
Why?
Carboplatin
1
2011
168
0.080
Why?
Pneumonectomy
3
2017
169
0.080
Why?
Protein Kinase Inhibitors
1
2016
983
0.080
Why?
World Health Organization
1
2010
104
0.080
Why?
Chromosomes, Human, X
1
2010
76
0.080
Why?
Lipid Metabolism
1
2013
533
0.070
Why?
Tidal Volume
1
2010
108
0.070
Why?
Pneumonia, Ventilator-Associated
1
2010
58
0.070
Why?
Fibroma
1
2009
21
0.070
Why?
Survival Analysis
4
2017
1378
0.070
Why?
Genes, p16
1
2009
13
0.070
Why?
Transforming Growth Factor beta
1
2012
467
0.070
Why?
Dietary Supplements
1
2013
587
0.070
Why?
Cell Dedifferentiation
1
2009
31
0.070
Why?
Positive-Pressure Respiration
1
2010
115
0.070
Why?
Tomography, X-Ray Computed
3
2008
2786
0.070
Why?
Reproducibility of Results
4
2016
3416
0.070
Why?
Aged, 80 and over
6
2013
8391
0.070
Why?
Carcinoma, Renal Cell
1
2010
231
0.060
Why?
Tissue Fixation
2
2008
35
0.060
Why?
Chromosomes, Human, Pair 13
1
2006
15
0.060
Why?
Collagen
1
2009
460
0.060
Why?
Cytodiagnosis
1
2006
31
0.060
Why?
Forkhead Box Protein O1
1
2006
36
0.060
Why?
Tumor Suppressor Protein p53
3
2009
530
0.060
Why?
Oncogene Proteins, Fusion
1
2008
213
0.060
Why?
DNA, Neoplasm
1
2006
160
0.060
Why?
Adenoma
1
2008
210
0.060
Why?
Kidney Neoplasms
1
2010
419
0.060
Why?
Gene Rearrangement
1
2006
156
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2240
0.060
Why?
Prostatic Neoplasms
1
2013
972
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2008
457
0.060
Why?
Pain Measurement
1
2008
573
0.050
Why?
Rare Diseases
1
2006
117
0.050
Why?
Coccidioides
1
2004
7
0.050
Why?
Coccidioidomycosis
1
2004
8
0.050
Why?
Shoulder Pain
1
2004
37
0.050
Why?
Salivary Gland Neoplasms
1
2004
39
0.050
Why?
Genetic Predisposition to Disease
1
2013
2488
0.050
Why?
Dose-Response Relationship, Drug
2
2019
2022
0.050
Why?
Taxoids
1
2004
115
0.050
Why?
Mesothelioma
1
2004
50
0.050
Why?
Epigenesis, Genetic
1
2009
712
0.050
Why?
Antibodies, Monoclonal
1
2011
1512
0.050
Why?
Prognosis
4
2016
4351
0.050
Why?
Antineoplastic Agents, Phytogenic
1
2004
178
0.050
Why?
Osteosarcoma
1
2004
100
0.050
Why?
Tissue Array Analysis
2
2013
49
0.050
Why?
Sarcoma, Synovial
1
2002
20
0.050
Why?
Fibroma, Desmoplastic
1
2002
2
0.050
Why?
Ribs
1
2002
35
0.040
Why?
Artifacts
1
2003
143
0.040
Why?
Fibroblasts
1
2007
1034
0.040
Why?
Predictive Value of Tests
2
2008
2113
0.040
Why?
Treatment Outcome
4
2017
11821
0.040
Why?
Drug Administration Schedule
2
2017
790
0.040
Why?
Leukopenia
2
2014
33
0.040
Why?
Fowlpox virus
1
2019
1
0.040
Why?
Administration, Intravesical
1
2019
15
0.040
Why?
Antineoplastic Agents
1
2011
2219
0.040
Why?
Pancreatic Neoplasms
1
2008
944
0.040
Why?
Paraffin Embedding
2
2010
33
0.040
Why?
Follow-Up Studies
3
2017
5439
0.040
Why?
Phosphorylation
2
2013
1724
0.030
Why?
Incidence
2
2017
2936
0.030
Why?
Practice Guidelines as Topic
1
2006
1591
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
974
0.030
Why?
Practice Patterns, Physicians'
1
2006
1408
0.030
Why?
International Agencies
1
2016
30
0.030
Why?
Gene Expression Profiling
1
2004
1792
0.030
Why?
Chemotherapy, Adjuvant
1
2017
429
0.030
Why?
Proto-Oncogene Proteins c-met
1
2016
76
0.030
Why?
Neoadjuvant Therapy
1
2019
475
0.030
Why?
Recombinant Proteins
1
2019
1361
0.030
Why?
Sensitivity and Specificity
2
2010
1998
0.030
Why?
Chemotherapy-Induced Febrile Neutropenia
1
2014
2
0.030
Why?
Early Termination of Clinical Trials
1
2014
18
0.030
Why?
Myxoma
1
2013
11
0.020
Why?
Adolescent
4
2006
22557
0.020
Why?
Carcinoma, Small Cell
1
2014
172
0.020
Why?
Histocytochemistry
1
2013
77
0.020
Why?
Alopecia
1
2013
33
0.020
Why?
Patient Selection
1
2017
728
0.020
Why?
Genes, p53
1
2013
56
0.020
Why?
Chemoprevention
1
2013
91
0.020
Why?
Cohort Studies
2
2014
6077
0.020
Why?
Demography
1
2013
274
0.020
Why?
Tamoxifen
1
2013
193
0.020
Why?
Postoperative Period
1
2013
355
0.020
Why?
Constipation
1
2013
98
0.020
Why?
Microscopy
1
2013
147
0.020
Why?
Estrogen Receptor alpha
1
2013
154
0.020
Why?
Gene Deletion
1
2013
385
0.020
Why?
Longevity
1
2013
179
0.020
Why?
Tumor Cells, Cultured
1
2013
882
0.020
Why?
Leukocytes, Mononuclear
1
2014
585
0.020
Why?
Fatigue
1
2013
363
0.020
Why?
Kaplan-Meier Estimate
1
2013
970
0.020
Why?
Randomized Controlled Trials as Topic
1
2017
1763
0.020
Why?
Cetuximab
1
2011
110
0.020
Why?
Neoplasm Metastasis
1
2013
693
0.020
Why?
Pulmonary Gas Exchange
1
2010
117
0.020
Why?
Estradiol
1
2013
517
0.020
Why?
Longitudinal Studies
1
2017
3017
0.020
Why?
Respiratory Mechanics
1
2010
74
0.020
Why?
Chromosome Aberrations
1
2010
167
0.020
Why?
Chromosomes, Human, Pair 17
1
2009
54
0.020
Why?
Karyotyping
1
2009
106
0.020
Why?
Adenocarcinoma
1
2016
927
0.020
Why?
Green Fluorescent Proteins
1
2011
408
0.020
Why?
Neoplasms, Adipose Tissue
1
2009
1
0.020
Why?
Homeostasis
1
2013
646
0.020
Why?
Child
2
2006
22693
0.020
Why?
Retinoblastoma Protein
1
2009
63
0.020
Why?
Pilot Projects
1
2014
1888
0.020
Why?
Double-Blind Method
1
2013
2070
0.020
Why?
Cell Movement
1
2013
951
0.020
Why?
Carbon Dioxide
1
2010
228
0.020
Why?
Connective Tissue Cells
1
2007
2
0.020
Why?
Fixatives
1
2007
13
0.020
Why?
Respiratory Function Tests
1
2010
543
0.020
Why?
Animals
3
2019
38107
0.020
Why?
Antibody Specificity
1
2007
181
0.020
Why?
Formaldehyde
1
2007
66
0.020
Why?
Stromal Cells
1
2007
123
0.020
Why?
Swine
1
2010
821
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2010
642
0.020
Why?
Thymus Gland
1
2007
310
0.020
Why?
Mitochondria
1
2013
997
0.010
Why?
Young Adult
2
2013
14330
0.010
Why?
Specimen Handling
1
2008
178
0.010
Why?
Anesthesia
1
2010
257
0.010
Why?
Severity of Illness Index
1
2014
2921
0.010
Why?
Coronary Vessels
1
2007
245
0.010
Why?
Cell Proliferation
1
2013
2502
0.010
Why?
Neoplasm Proteins
1
2009
444
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
846
0.010
Why?
Cell Line, Tumor
1
2013
3545
0.010
Why?
Itraconazole
1
2004
8
0.010
Why?
Preoperative Care
1
2008
396
0.010
Why?
Metacarpus
1
2004
6
0.010
Why?
Phenotype
1
2013
3206
0.010
Why?
Giant Cell Tumor of Bone
1
2004
8
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2011
992
0.010
Why?
Hemodynamics
1
2010
1114
0.010
Why?
Agranulocytosis
1
2004
30
0.010
Why?
Oxygen
1
2010
997
0.010
Why?
Promoter Regions, Genetic
1
2009
1242
0.010
Why?
Pneumonia
1
2010
635
0.010
Why?
Antifungal Agents
1
2004
153
0.010
Why?
Injections, Subcutaneous
1
2004
170
0.010
Why?
Edema
1
2004
131
0.010
Why?
Retrospective Studies
2
2014
17438
0.010
Why?
Infusions, Intravenous
1
2004
432
0.010
Why?
Secondary Prevention
1
2004
248
0.010
Why?
Skin
1
2007
701
0.010
Why?
DNA Topoisomerases, Type II
1
2002
42
0.010
Why?
Biomarkers
1
2014
4340
0.010
Why?
Ki-67 Antigen
1
2002
120
0.010
Why?
Radiography
1
2004
861
0.010
Why?
Cytokines
1
2010
2081
0.010
Why?
RNA, Messenger
1
2010
2791
0.010
Why?
Biopsy
1
2004
1075
0.010
Why?
Antigens, Neoplasm
1
2002
271
0.010
Why?
Survival Rate
1
2004
2092
0.010
Why?
Health Status
1
2004
827
0.010
Why?
Signal Transduction
1
2012
5246
0.010
Why?
Muscle, Skeletal
1
2007
1818
0.010
Why?
Lung
1
2010
4122
0.010
Why?
Mice
1
2013
18297
0.010
Why?
DNA-Binding Proteins
1
2002
1468
0.010
Why?
United States
1
2004
16136
0.000
Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)